重新定义血肿扩大:纳入脑室内出血增长
本研究基于PREDICT-ICH队列256例轻中度脑出血患者,比较标准血肿扩大定义与纳入脑室内出血(IVH)增长的新定义对90天不良结局的预测能力。结果显示,新定义(≥6 mL或≥33%或任何IVH)敏感性提高至63.8%,特异性75.2%,总体准确率显著改善(P=0.013),校正后与90天不良结局风险增加2.55倍相关。
要点
- 纳入IVH增长的新定义较标准定义敏感性更高,特异性仅轻微下降
- 新定义预测90天不良结局的总体准确率显著优于标准定义
- 轻中度脑出血患者中,任何IVH出现或IVH扩大≥1 mL均应纳入血肿扩大评估
核心结论
- 在轻中度脑出血患者中,将IVH增长纳入血肿扩大定义可提高敏感性并改善90天结局预测。
研究设计与样本
- 基于PREDICT-ICH研究数据的诊断准确性分析,纳入256例符合条件的脑出血患者。
主要发现
- 256例中127例(49.6%)90天mRS为4-6分。
- 标准定义(n=80)敏感性45.7%(95%CI 36.8-54.7),特异性82.9%(95%CI 75.3-88.9)。
- 新定义≥6 mL或≥33%或任何IVH(n=113)敏感性63.8%(95%CI 54.8-72.1),特异性75.2%(95%CI 66.8-82.4),总体准确率显著改善(P=0.013)。
- 校正协变量后,新定义与90天不良结局风险增加2.55倍相关(95%CI 1.31-4.94)。
- 另一新定义≥6 mL或≥33%或IVH扩大≥1 mL表现相似:敏感性56.7%(95%CI 47.6-65.5),特异性78.3%(95%CI 40.2-85.1),aOR 2.40(95%CI 1.23-4.69)。
关键数值与推荐
- 标准血肿扩大定义:≥6 mL或≥33%。
- 修订定义一:≥6 mL或≥33%或任何IVH。
- 修订定义二:≥6 mL或≥33%或IVH扩大≥1 mL。
临床怎么用
- 在轻中度脑出血患者中评估血肿扩大时,应考虑将IVH出现或扩大纳入定义以改善风险分层。
局限性
- 研究基于PREDICT-ICH单队列数据,结论需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Definitions of significant hematoma expansion traditionally focus on changes in intraparenchymal volume. The presence of intraventricular hemorrhage (IVH) is a predictor of poor outcome, but current definitions of hematoma expansion do not include IVH expansion. We evaluated whether including IVH expansion to current definitions of hematoma expansion improves the ability to predict 90-day outcome. Methods- Using data from the PREDICT-ICH study (Predicting Hematoma Growth and Outcome in Intracerebral Hemorrhage Using Contrast Bolus CT), we compared a standard definition of hematoma expansion (≥6 mL or ≥33%) to revised definitions that includes new IVH development or expansion (≥6 mL or ≥33% or any IVH; ≥6 mL or ≥33% or IVH expansion ≥1 mL). The primary outcome was poor clinical outcome (modified Rankin Scale score, 4-6) at 90 days. Diagnostic accuracy measures were calculated for each definition, and C statistics for each definition were compared using nonparametric methods. Results- Of the 256 patients eligible for primary analysis, 127 (49.6%) had a modified Rankin Scale score of 4 to 6. Sensitivity and specificity for the standard definition (n=80) were 45.7% (95% CI, 36.8-54.7) and 82.9% (95% CI, 75.3-88.9), respectively. The revised definition, ≥6 mL or ≥33% or any IVH (n=113), possessed a sensitivity of 63.8% (95% CI, 54.8-72.1) and specificity of 75.2% (95% CI, 66.8-82.4). Overall accuracy was significantly improved with the revised definition (P=0.013) and after adjusting for relevant covariates, was associated with a 2.55-fold increased odds (95% CI, 1.31-4.94) of poor outcome at 90 days. A second revised definition, ≥6 mL or ≥33% or IVH expansion ≥1 mL, performed similarly (sensitivity, 56.7% [95% CI, 47.6-65.5]; specificity, 78.3% [95% CI, 40.2-85.1]; aOR, 2.40 [95% CI, 1.23-4.69]). Conclusions- In patients with mild-to-moderate ICH, including IVH expansion to the definition of hematoma expansion improves sensitivity with only minimal decreases to specificity and improves overall prediction of 90-day outcome.
引用
- Yogendrakumar V, Ramsay T, Fergusson DA, et al. Redefining Hematoma Expansion With the Inclusion of Intraventricular Hemorrhage Growth. Stroke. 2020. PMID: 32078498. doi:10.1161/STROKEAHA.119.027451
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。